These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9427153)
1. Absence of common trifunctional protein mutation in patients with Alpers disease. Yang Z; Youil R; Thorburn D; Chow CW; Cotton RG; Baldwin GS J Inherit Metab Dis; 1997 Nov; 20(6):828-30. PubMed ID: 9427153 [No Abstract] [Full Text] [Related]
2. Transcription of the faoAB operon which encodes the HDT multienzyme complex involved in fatty acid beta-oxidation in Pseudomonas fragi B-0771. Sato S; Ozeki Y; Kawaguchi A J Biochem; 1994 Feb; 115(2):286-92. PubMed ID: 8206878 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for channelling mechanism of a fatty acid beta-oxidation multienzyme complex. Ishikawa M; Tsuchiya D; Oyama T; Tsunaka Y; Morikawa K EMBO J; 2004 Jul; 23(14):2745-54. PubMed ID: 15229654 [TBL] [Abstract][Full Text] [Related]
4. Kinetic implications of metabolite channelling in beta-oxidation. Cornish-Bowden A Biochem Soc Trans; 1994 May; 22(2):451-4. PubMed ID: 7958344 [No Abstract] [Full Text] [Related]
5. A male child with the rumpshaker mutation, X-linked spastic paraplegia/Pelizaeus-Merzbacher disease and lysinuria. Naidu S; Dlouhy SR; Geraghty MT; Hodes ME J Inherit Metab Dis; 1997 Nov; 20(6):811-6. PubMed ID: 9427151 [TBL] [Abstract][Full Text] [Related]
6. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. Ibdah JA; Bennett MJ; Rinaldo P; Zhao Y; Gibson B; Sims HF; Strauss AW N Engl J Med; 1999 Jun; 340(22):1723-31. PubMed ID: 10352164 [TBL] [Abstract][Full Text] [Related]
8. A new inhibitor of mitochondrial fatty acid oxidation. Hashimoto T; Shindo Y; Souri M; Baldwin GS J Biochem; 1996 Jun; 119(6):1196-201. PubMed ID: 8827458 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches. Rector RS; Payne RM; Ibdah JA Adv Drug Deliv Rev; 2008; 60(13-14):1488-96. PubMed ID: 18652860 [TBL] [Abstract][Full Text] [Related]
10. Pelizaeus-Merzbacher disease: a novel mutation in the 5'-untranslated region of the proteolipid protein gene. Kawanishi C; Sugiyama N; Osaka H; Inoue K; Suzuki K; Onishi H; Yamada Y; Nezu A; Kimura S; Kosaka K Hum Mutat; 1996; 7(4):355-7. PubMed ID: 8723686 [No Abstract] [Full Text] [Related]
11. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Naviaux RK; Nguyen KV Ann Neurol; 2005 Sep; 58(3):491. PubMed ID: 16130100 [No Abstract] [Full Text] [Related]
12. Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidation. Baldwin GS; Abbott FS; Nau H FEBS Lett; 1996 Apr; 384(1):58-60. PubMed ID: 8797803 [TBL] [Abstract][Full Text] [Related]
13. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes. Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439 [TBL] [Abstract][Full Text] [Related]
14. Complete deficiency of mitochondrial trifunctional protein due to a novel mutation within the beta-subunit of the mitochondrial trifunctional protein gene leads to failure of long-chain fatty acid beta-oxidation with fatal outcome. Schwab KO; Ensenauer R; Matern D; Uyanik G; Schnieders B; Wanders RA; Lehnert W Eur J Pediatr; 2003 Feb; 162(2):90-5. PubMed ID: 12548384 [TBL] [Abstract][Full Text] [Related]
15. Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. Olpin SE; Clark S; Andresen BS; Bischoff C; Olsen RK; Gregersen N; Chakrapani A; Downing M; Manning NJ; Sharrard M; Bonham JR; Muntoni F; Turnbull DN; Pourfarzam M J Inherit Metab Dis; 2005; 28(4):533-44. PubMed ID: 15902556 [TBL] [Abstract][Full Text] [Related]
16. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Wanders RJ; IJlst L; Poggi F; Bonnefont JP; Munnich A; Brivet M; Rabier D; Saudubray JM Biochem Biophys Res Commun; 1992 Nov; 188(3):1139-45. PubMed ID: 1445348 [TBL] [Abstract][Full Text] [Related]
17. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Naviaux RK; Nguyen KV Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency. Jones PM; Butt Y; Bennett MJ Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125 [TBL] [Abstract][Full Text] [Related]
19. [Screening for the G1528C mutation in long chain fatty acid oxidation enzyme in Han nationality in Beijing population]. Zhu JM; Yang Z; Yu M; Wang R; Ye RH; Yang HX; Zhai GR; Wang Q Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 37(1):72-4. PubMed ID: 15719047 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation. Street JM; Singh H; Poulos A Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]